Generic Ozempic Launch in India: Weight-Loss Drug to Cost $14

India's pharmaceutical industry is set to launch generic versions of Ozempic, with prices starting at just $14, following the expiration of Novo Nordisk's patent on semaglutide. This development is poised to significantly impact the global obesity treatment market, making effective weight-loss medications more accessible to millions. With the entry of affordable alternatives in India, stakeholders are closely monitoring potential changes in market dynamics, including increased competition and pressures on pricing in branded drug markets. The cost-effectiveness of these drugs could also lead to broader usage and advocate for healthier lifestyles across developing nations.